Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Interventional cardiology

Effectiveness of stents in high-risk and 'real world' patients

Nature Reviews Cardiology volume 6, pages 502–503 (2009)Cite this article

There are concerns about long-term outcomes associated with drug-eluting stent implantation in high-risk and 'real world' patients, and few data from these settings have been published. Two new papers add to our knowledge on drug-eluting stent use in acute myocardial infarction and for off-label indications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Stone, G. W. et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med. 356, 998–1008 (2007).

    Article  CAS  Google Scholar 

  2. Mauri, L. et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 356, 1020–1029 (2007).

    Article  CAS  Google Scholar 

  3. Stone, G. W. et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N. Engl. J. Med. 360, 1946–1959 (2009).

    Article  CAS  Google Scholar 

  4. James, S. K. et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N. Engl. J. Med. 360, 1933–1945 (2009).

    Article  CAS  Google Scholar 

  5. Brar, S. S. et al. Use of drug-eluting stents in acute myocardial Infarction: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 53, 1677–1689 (2009).

    Article  Google Scholar 

  6. Roukoz, H. et al. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am. J. Med. 122, 581.e1–10 (2009).

    Article  Google Scholar 

  7. Mehran, R. et al. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Am. Heart J. 156, 44–56 (2008).

    Article  CAS  Google Scholar 

  8. Stone, G. W. et al. Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 358, 2218–2230 (2008).

    Article  CAS  Google Scholar 

  9. Lagerqvist, B. et al. Long term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med. 356, 1009–1019 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Respiratory and Morphologic Sciences Department, Cardiovascular, Umberto I Hospital, Sapienza University of Rome, Italy

    Gennaro Sardella & Massimo Mancone

Authors
  1. Gennaro Sardella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimo Mancone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gennaro Sardella.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sardella, G., Mancone, M. Effectiveness of stents in high-risk and 'real world' patients. Nat Rev Cardiol 6, 502–503 (2009). https://doi.org/10.1038/nrcardio.2009.115

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2009.115

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing